AMLX Operating Cash Flow (Statement)
Amylyx Pharmaceuticals Inc · Operating Cash Flow (Statement)
AMLX Operating Cash Flow (Statement)
Latest reported-$126.58Mperiod ending
AMLX TTM Cash from Operations (-$55.44M → -$126.58M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AMLX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -126,577,000 | |
| -120,401,000 | |
| -123,343,000 | |
| -154,448,000 | |
| -165,650,000 | |
| -206,982,000 | |
| -167,647,000 | |
| -95,088,000 | |
| -58,687,000 | |
| 16,502,000 | |
| 11,919,000 | |
| -51,329,000 | |
| -89,238,000 | |
| -144,309,000 | |
| -179,871,000 | |
| -158,418,000 | |
| -136,205,000 | |
| -102,790,000 | |
| -74,799,000 | |
| -55,443,000 |